Press-release for stocks related to antibody for SNY

tags : Antibody symbols : SNY

save search

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published: 2024-04-10 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K

Health Technology

| -9.62% | O: -3.85% H: 1.2% C: 0.8%
iph45 pharma drug candidate antibody preclinical

Biond Biologics Announces Presentation of BND-35, a Novel Anti-ILT3 Antibody for Remodeling the Tumor Microenvironment, at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.72% | O: 1.93% H: 0.0% C: 0.0%
bnd-35 antibody association presentation cancer tumor research meeting

Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology

| -8.3% | O: 0.21% H: 0.97% C: 0.7%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -5.15% | O: 0.05% H: 0.14% C: -0.93%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.85% | O: -1.58% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| -1.31% | O: -0.7% H: 0.73% C: -0.16%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| -8.4% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -6.03% | O: -0.02% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K

Health Technology

| -6.03% | O: -0.27% H: 1.26% C: 0.84%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| -2.43% | O: 0.2% H: 1.14% C: -1.18%
antibody therapeutics market

Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.01% | O: 0.0% H: 0.8% C: 0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.29% | O: -0.45% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K

Health Technology

| -8.56% | O: 0.78% H: 1.93% C: 0.97%
iph45 pharma drug antibody preclinical

Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.38% | O: 2.72% H: 0.0% C: -0.8%
TEVA | $12.86 0.63% 0.0% 10M

Health Technology

| 1.23% | O: 1.31% H: 0.67% C: -0.91%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -1.56% | O: 2.53% H: 0.0% C: 0.0%
antibody meeting teva

Biomunex Pharmaceuticals Announces the Start of a Phase 1 Clinical Trial for Its First-in-class Bispecific Antibody for the Treatment of Cancer
Published: 2024-01-24 (Crawled : 15:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -10.09% | O: -3.01% H: 0.69% C: -0.75%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -9.13% | O: 0.92% H: 0.0% C: 0.0%
antibody start cancer treatment pharmaceuticals trial

Global Antibody Fragments Market Research Report 2023: Market to Reach $9.6 Billion by 2028 - Increasing Investments in Biopharmaceuticals Driving Growth
Published: 2024-01-15 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -12.55% | O: -2.03% H: 0.05% C: 0.05%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -13.37% | O: 0.16% H: 0.43% C: 0.07%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 16.78% | O: 0.15% H: 0.59% C: -1.45%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 1.46% | O: -0.49% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -13.1% | O: -1.34% H: 0.0% C: 0.0%
investments report antibody reach research global growth market

Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published: 2023-12-07 (Crawled : 15:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.64% | O: -1.66% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -4.09% | O: -0.97% H: 0.3% C: -0.19%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.57% | O: -1.61% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 13.95% | O: 1.97% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -1.64% | O: -1.19% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K

Health Technology

| 7.83% | O: 0.51% H: 1.22% C: 1.09%
IMNM | $15.5 -9.78% -10.84% 2.1M

Health Technology

| 119.13% | O: -0.64% H: 1.67% C: -1.16%
BIIB | $194.39 2.03% 1.99% 1.6M

Health Technology

| -16.56% | O: 1.67% H: 0.91% C: 0.57%
antibody therapeutics market

Global Human African Trypanosomiasis (Sleeping Sickness) Market Research Report 2023: Distribution, Clinical Features, Diagnosis, Antibody and Parasite Detection, Future Perspectives, & Screening
Published: 2023-11-10 (Crawled : 20:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| Email alert Add to watchlist
report antibody research global market

Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications
Published: 2023-11-06 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 2.04% | O: 0.16% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -0.15% | O: 0.21% H: 0.0% C: 0.0%
partnership candidate antibody tumor

Monoclonal Antibodies: A Transformative Force in Biopharmaceuticals, Driving Growth in Antibody Discovery Services and Platforms
Published: 2023-10-19 (Crawled : 17:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -5.09% | O: -0.73% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 23.64% | O: -1.17% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -15.31% | O: -2.42% H: 0.0% C: 0.0%
IMAB | $1.81 0.56% 0.55% 340K

Health Technology

| 36.36% | O: -0.76% H: 3.05% C: -0.38%
services antibody growth

4 Common Questions Answered About the New Monoclonal Antibody to Help Prevent Severe RSV in Babies
Published: 2023-10-11 (Crawled : 10:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -16.1% | O: 1.1% H: 0.0% C: 0.0%
antibody rsv

Global Respiratory Syncytial Virus (RSV) Vaccine and Antibody Pipeline Market Forecasts to 2030
Published: 2023-09-15 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -14.44% | O: 1.53% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800

Health Technology

| 1.73% | O: 3.97% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -16.57% | O: 0.82% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

Health Technology

| 0.72% | O: 1.27% H: 0.38% C: -0.54%
antibody vaccine respiratory pipeline global virus market

Regeneron Announces Agreement with BARDA Supporting Development of Next-Generation Antibody Therapy for COVID-19 Prevention
Published: 2023-08-22 (Crawled : 18:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -15.78% | O: -0.86% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K

Health Technology

| 7.2% | O: 0.52% H: 0.3% C: -0.5%
covid-19 antibody agreement therapy

Innovent Announces the Preclinical Results of IBI363 (PD-1/IL-2 Bispecific Antibody Fusion Protein) were Published in Nature Cancer
Published: 2023-08-08 (Crawled : 03:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -11.89% | O: 1.09% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M

Health Technology

| -16.99% | O: 2.58% H: 0.41% C: -1.13%
ibi363 antibody cancer preclinical results

AstraZeneca, Sanofi Win CDC Support for Preventive RSV Antibody for Infants
Published: 2023-08-04 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -9.29% | O: 2.43% H: 0.0% C: 0.0%
antibody rsv sanofi

FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
Published: 2023-07-17 (Crawled : 22:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology